Macular degeneration may be classified by the age of onset of symptoms, fundus appearance, and/or hereditary patterns. The measurement of spectral threshold may be used in the categorisation of the degeneration as an aid in differential diagnosis. Although there is no adequate treatment for it, distinguishing between the juvenile macular degenerations and senile macular degeneration may have importance in predicting the course of loss of visual acuity as well in understanding the hereditary factors for the purpose of genetic counselling.
In macular degeneration the initial presenting symptom is a loss of central visual acuity over the course of a few months to a year. Routine testing on our patients includes ophthalmoscopy, visual fields (including an Amsler grid test), fluorescein angiography, electroretinography (ERG), electrooculography (EOG), and visually evoked potentials (VEP). Lack of positive results in any of these tests in a young person might indicate malingering.
Indication of a central vision defect on the Amsler chart in a patient in his second or third decade without other signs or family history of macular degeneration may leave one in doubt as to the source of the vision loss. Spectral sensitivity curves measured in patients with central vision losses down to visual acuity at 6/60 may show a uniquely high sensitivity in the blue region as compared with the sensitivity to spectral lights in the green to red range-for example in Stargardt's juvenile macular degeneration (atrophic fundus flavimaculatus). ' reproducibility of the spectral threshold settings (we have satisfactorily measured children as young as 7 years old on the apparatus at the Manchester Royal Eye Hospital).
Methods
The methods used are described by Alvarez et al. 3 The subject's task was to adjust the intensity of a 10, 05 second test flash until it was just visible. In addition to the 1000 trolonds (td) white background used in the previous paper, the following 3 coloured background lights were used in some experiments: blue, Ilford filter 305, intensity 1000 td; purple, Kodak filters no. 34 plus two CC50R, 1000 td; yellow, Schott OG530, 10000 td.
Results
A normal spectral threshold (average for 18 eyes) is shown in Fig. la Patient2. An 18-year-old female reported a gradual loss of vision over the past 9 years; acuity was 6/36 in each eye. The fundus showed discrete lesions and some pigment clumping at the macula. ERG and EOG were normal. Flash VEPs were normal, while pattern VEP showed no response. Fluorescein angiography facilitated identification ofmacular lesions in both eyes. Feathery hyperfluorescent spots at the maculas, symmetrical in the 2 eyes, were typical of the commonest type of atrophic macular degeneration, Stargardt's disease.'2 The profile of her spectral sensitivity curve (Fig. lc) was very different from either the average normal or that of patient 1 (SMD). Sensitivity in the red/green area of the spectrum was very depressed (1-2 log units of sensitivity) relative to normal, while the detection of a blue test on a white background seemed to have been spared. The results of the 100-hue test for the right eye are shown in Fig.  2 . There was a large error score indicating a colour defect was present. However, there was no determinable axis to identify the type of colour defect or to distinguish this central vision defect from any other in relation to the unique response measured by spectral sensitivities.
A summary of sensitivities for 5 eyes with other diagnostic evidence of JMD is shown in Fig. 3 . An average normal spectral sensitivity is included (Fig.  3a) for comparison. The diagnosis of JMD was confirmed by family history, early age of onset, and/or by fluorescein angiography in these cases. No central scotoma was noted on the Amsler grid, and fixation was checked with a projection ophthalmoscope (fixation was unsteady in some patients but there was no gross eccentric fixation).
Patient 3. An 18-year-old female had reduction in visual acuity (approximately 6/60 right and left) over the last 2 to 3 years. The vision was subjectively worse in bright daylight. There was no family history of any eye disease. The fundus appeared normal. The ERG, EOG, and flash VEPs were also normal. Spectral sensitivities for 0-5 second flashes on a white background (Fig. 4a) gave the notable profile (similar to that of the patients in Fig. 3 ) of a large drop in the red/green sensitivity while preserving a normal threshold for blue. This response is unlike the loss in spectral sensitivities noted for other diseases34 and similar to that of the diagnosed JMD patients (Figs. 1  and 3 ).
Patient 4. A drop in visual acuity from 6/5 to 6/12 over a 2-year period was noted in a 27-year-old female. Her general health was good and there was no family history of any eye disorders. Fundus, ERG, and VEPs were normal. Spectral sensitivity on a white background (Fig. 4b) showed a depressed response to the test flash throughout the spectrum (compared with the normal in Fig. 4a) , unlike either the SMD or the JMD curves. By means of Marres methods of applying a coloured background to The results of spectral sensitivity measurements are quite different from those of central vision loss due to SMD-for example, in patient 1 described here. The severe loss of blue sensitivity as well as some loss in the longer wavelengths of the spectrum has been noted in all other SMD patients whose spectral sensitivity we have measured.
Loss of central acuity may lead some patients to have unsteady or slightly eccentric fixation. Although using an eccentric fixation point may increase the blue peak sensitivity relative to the green/red range of the spectrum, observed changes with eccentric viewing in the normal were not sufficient to explain the difference seen in the patients here.
CONCLUSION
Macular degenerations may be classified by age of onset, hereditary pattern, and/or by some of the routine tests previously mentioned. The ability to diagnose a sudden loss of visual acuity as a primary atrophic macular degeneration of a type first described by Stargardt may be important in (1) genetic counselling and in a search for afflicted family members; (2) prediction of the course of the disease (the visual acuity rarely progresses to worse than 6/60 in this type of JMD1; (3) distinguishing a JMD patient from another cause of loss of central acuity, including malingering.
The measurement of a spectral sensitivity may aid in the diagnosis of JMD. The spectral thresholds measured can vary with ocular disease as discussed in the previous article, but only in JMD is blue sensitivity spared while considerable depression may be observed in green/red sensitivity.
